Hsiu-Wen Tsai1, Kevin M Motz1, Dacheng Ding1, Ioan Lina1, Michael K Murphy2, Dimitri Benner3, Michael Feeley4, Jody Hooper5, Alexander T Hillel1. 1. Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins School of Medicine, Baltimore, Maryland, U.S.A. 2. Department of Otolaryngology, State University of New York Upstate Medical University, Syracuse, New York, U.S.A. 3. Medical University of Vienna, Vienna, Austria. 4. Department of Biomedical Engineering, Widener University, Chester, Pennsylvania, U.S.A. 5. Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, U.S.A.
Abstract
OBJECTIVES/HYPOTHESIS: Glutamine metabolism is a critical energy source for iatrogenic laryngotracheal stenosis (iLTS) scar fibroblasts, and glutaminase (GLS) is an essential enzyme converting glutamine to glutamate. We hypothesize that the GLS-specific inhibitor BPTES will block glutaminolysis and reduce iLTS scar fibroblast proliferation, collagen deposition, and fibroblast metabolism in vitro. STUDY DESIGN: Test-tube Lab Research. METHODS: Immunohistochemistry of a cricotracheal resection (n = 1) and a normal airway specimen (n = 1) were assessed for GLS expression. GLS expression was assessed in brush biopsies of subglottic/tracheal fibrosis and normal airway from patients with iLTS (n = 6). Fibroblasts were isolated and cultured from biopsies of subglottic/tracheal fibrosis (n = 6). Fibroblast were treated with BPTES and BPTES + dimethyl α-ketoglutarate (DMK), an analogue of the downstream product of GLS. Fibroblast proliferation, gene expression, protein production, and metabolism were assessed in all treatment conditions and compared to control. RESULTS: GLS was overexpressed in brush biopsies of iLTS scar specimens (P = .029) compared to normal controls. In vitro, BPTES inhibited iLTS scar fibroblast proliferation (P = .007), collagen I (Col I) (P < .0001), collagen III (P = .004), and α-smooth muscle actin (P = .0025) gene expression and protein production (P = .031). Metabolic analysis demonstrated that BPTES reduced glycolytic reserve (P = .007) but had no effects on mitochondrial oxidative phosphorylation. DMK rescued BPTES inhibition of Col I gene expression (P = .0018) and protein production (P = .021). CONCLUSIONS: GLS is overexpressed in iLTS scar. Blockage of GLS with BPTES significantly inhibits iLTS scar fibroblasts proliferation and function, demonstrating a critical role for GLS in iLTS. Targeting GLS to inhibit glutaminolysis may be a successful strategy to reverse scar formation in the airway. LEVEL OF EVIDENCE: NA Laryngoscope, 2020.
OBJECTIVES/HYPOTHESIS: Glutamine metabolism is a critical energy source for iatrogenic laryngotracheal stenosis (iLTS) scar fibroblasts, and glutaminase (GLS) is an essential enzyme converting glutamine to glutamate. We hypothesize that the GLS-specific inhibitor BPTES will block glutaminolysis and reduce iLTS scar fibroblast proliferation, collagen deposition, and fibroblast metabolism in vitro. STUDY DESIGN: Test-tube Lab Research. METHODS: Immunohistochemistry of a cricotracheal resection (n = 1) and a normal airway specimen (n = 1) were assessed for GLS expression. GLS expression was assessed in brush biopsies of subglottic/tracheal fibrosis and normal airway from patients with iLTS (n = 6). Fibroblasts were isolated and cultured from biopsies of subglottic/tracheal fibrosis (n = 6). Fibroblast were treated with BPTES and BPTES + dimethyl α-ketoglutarate (DMK), an analogue of the downstream product of GLS. Fibroblast proliferation, gene expression, protein production, and metabolism were assessed in all treatment conditions and compared to control. RESULTS:GLS was overexpressed in brush biopsies of iLTS scar specimens (P = .029) compared to normal controls. In vitro, BPTES inhibited iLTS scar fibroblast proliferation (P = .007), collagen I (Col I) (P < .0001), collagen III (P = .004), and α-smooth muscle actin (P = .0025) gene expression and protein production (P = .031). Metabolic analysis demonstrated that BPTES reduced glycolytic reserve (P = .007) but had no effects on mitochondrial oxidative phosphorylation. DMK rescued BPTES inhibition of Col I gene expression (P = .0018) and protein production (P = .021). CONCLUSIONS:GLS is overexpressed in iLTS scar. Blockage of GLS with BPTES significantly inhibits iLTS scar fibroblasts proliferation and function, demonstrating a critical role for GLS in iLTS. Targeting GLS to inhibit glutaminolysis may be a successful strategy to reverse scar formation in the airway. LEVEL OF EVIDENCE: NA Laryngoscope, 2020.
Authors: Garret Ma; Idris Samad; Kevin Motz; Linda X Yin; Madhavi V Duvvuri; Dacheng Ding; Daryan R Namba; Jennifer H Elisseeff; Maureen R Horton; Alexander T Hillel Journal: Laryngoscope Date: 2016-09-01 Impact factor: 3.325
Authors: Michael K Murphy; Kevin M Motz; Dacheng Ding; Linda Yin; Madhavi Duvvuri; Michael Feeley; Alexander T Hillel Journal: Laryngoscope Date: 2017-09-20 Impact factor: 3.325
Authors: Alexander Gelbard; David O Francis; Vlad C Sandulache; John C Simmons; Donald T Donovan; Julina Ongkasuwan Journal: Laryngoscope Date: 2014-10-07 Impact factor: 3.325
Authors: Alexander T Hillel; Idris Samad; Garret Ma; Dacheng Ding; Kaitlyn Sadtler; Jonathan D Powell; Andrew P Lane; Maureen R Horton Journal: Otolaryngol Head Neck Surg Date: 2015-06-17 Impact factor: 3.497
Authors: A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson Journal: Proc Natl Acad Sci U S A Date: 2001-11-13 Impact factor: 11.205
Authors: Robert B Hamanaka; Erin M O'Leary; Leah J Witt; Yufeng Tian; Gizem A Gökalp; Angelo Y Meliton; Nickolai O Dulin; Gökhan M Mutlu Journal: Am J Respir Cell Mol Biol Date: 2019-11 Impact factor: 7.748
Authors: Hsiu-Wen Tsai; Ioan Lina; Kevin M Motz; Liam Chung; Dacheng Ding; Michael K Murphy; Michael Feeley; Jennifer H Elisseeff; Alexander T Hillel Journal: Laryngoscope Date: 2021-01-12 Impact factor: 2.970
Authors: Khalid Kamel; Colm J O'Brien; Alexander V Zhdanov; Dmitri B Papkovsky; Abbot F Clark; W Daniel Stamer; Mustapha Irnaten Journal: Invest Ophthalmol Vis Sci Date: 2020-11-02 Impact factor: 4.799
Authors: Ioan A Lina; Alexandra Berges; Rafael Ospino; Ruth J Davis; Kevin M Motz; Hsiu-Wen Tsai; Samuel Collins; Alexander T Hillel Journal: Otolaryngol Head Neck Surg Date: 2021-06-15 Impact factor: 3.497
Authors: Ioan Lina; Hsiu-Wen Tsai; Dacheng Ding; Ruth Davis; Kevin M Motz; Alexander T Hillel Journal: Laryngoscope Date: 2020-08-28 Impact factor: 2.970
Authors: Hussein Farah; Susanne N Wijesinghe; Thomas Nicholson; Fawzeyah Alnajjar; Michelangelo Certo; Abdullah Alghamdi; Edward T Davis; Stephen P Young; Claudio Mauro; Simon W Jones Journal: Int J Mol Sci Date: 2022-03-17 Impact factor: 5.923